Dataset: Transcription profiling by array of human glioblastoma cell lines after treatment with 5-aza-2'-deoxycitidine
Glioblastoma, the most aggressive and least treatable form of malignant glioma, is the most common human brain tumor. Although many...
Glioblastoma, the most aggressive and least treatable form of malignant glioma, is the most common human brain tumor. Although many regions of allelic loss occur in glioblastomas, relatively few tumor suppressor genes have been found mutated at such loci. To address the possibility that epigenetic alterations are an alternative means of glioblastoma gene inactivation, we coupled pharmacological manipulation of methylation with gene profiling to identify potential methylation-regulated, tumor-related genes. Triplicates of three short-term cultured glioblastomas were exposed to 5?M 5-aza-dC for 96 hours followed by cRNA hybridization to an oligonucleotide microarray (Affymetrix U133A). We based candidate gene selection on bioinformatics, RT-PCR, bisulfite sequencing, methylation-specific PCR and matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. Two genes identified in this manner, RUNX3 and Testin (TES), were subsequently shown to harbor frequent tumor-specific epigenetic alterations in primary glioblastomas. This overall approach therefore provides a powerful means to identify candidate tumor suppressor genes for subsequent evaluation and may lead to the identification of genes whose epigenetic dysregulation is integral to glioblastoma tumorigenesis. Duplicates of three short term cultured glioblastoma cell lines (internal IDs: GLI56;GLI60;GLI72) were either exposed to 5umol 5`aza-dC for 96h or left untreated. Total RNA was extracted of treated and untreated cells after 96h and hybridized to U133A chip. Gene expression profiles of treated and untreated cells were compared. Upregulation of gene expression in the treated (demethylated) samples was interpreted as potentially being regulated by methylation - pointing towards hypermethylation in the related cell line. Identification of novel tumor suppressor genes, regulated by methylation, was the overall goal.
- Species:
- human
- Samples:
- 12
- Source:
- E-GEOD-4717
- PubMed:
- 16909125
- Updated:
- Dec.12, 2014
- Registered:
- Jun.19, 2014
Sample | CellLine | Compound | Dose |
---|---|---|---|
GSE4717GSM106398 | GLI60 glioblastoma cell line | 5-aza-2'-deoxycytidine | 5 |
GSE4717GSM106503 | GLI72 glioblastoma cell line | none | |
GSE4717GSM106404 | GLI72 glioblastoma cell line | 5-aza-2'-deoxycytidine | 5 |
GSE4717GSM106404 | GLI72 glioblastoma cell line | 5-aza-2'-deoxycytidine | 5 |
GSE4717GSM106370 | GLI56 glioblastoma cell line | 5-aza-2'-deoxycytidine | 5 |
GSE4717GSM106498 | GLI56 glioblastoma cell line | none | |
GSE4717GSM106370 | GLI56 glioblastoma cell line | 5-aza-2'-deoxycytidine | 5 |
GSE4717GSM106500 | GLI60 glioblastoma cell line | none | |
GSE4717GSM106498 | GLI56 glioblastoma cell line | none | |
GSE4717GSM106503 | GLI72 glioblastoma cell line | none | |
GSE4717GSM106500 | GLI60 glioblastoma cell line | none | |
GSE4717GSM106398 | GLI60 glioblastoma cell line | 5-aza-2'-deoxycytidine | 5 |